HONG KONG, Apr 2, 2026 – (ACN Newswire) – Across the landscape of global biotech companies, the appointment of a senior executive often serves as a “barometer”—offering insights into a company’s pipeline potential and reflecting how industry veterans gauge the sector’s future.A clear signal of the company’s growth arrived in February 2026…
Read More
